In the castration-resistant prostate cancer context, ACSL3 promotes androgen synthesis through adrenal androgen dehydroepiandrosterone sulfate as a substrate, suggesting that ACSL3 may select for castration-resistant cancer cell populations. This evidence concerns the gene ACSL3 and prostate cancer.